Skip to main content
. 2011 Jan 7;29(8):1576–1582. doi: 10.1016/j.vaccine.2010.12.102

Table 3.

Antibody titers in sera of chickens following immunization with recombinant fowlpox virus co-expressing the infectious bronchitis virus (IBV) S1 gene and the chicken interferon-γ gene.

Group Time (weeks)
0a 1 2 3b 4 5 6
LX4 Vaccine 0 1145c 1731 1608 2418 6393 5948
Controld 0 0 0 135 2290 4984 4039
LHLJ04XI Vaccine 0 1145 1731 1608 2250 5805 5425
Control 0 0 0 135 2462 4014 4584
LHB Vaccine 0 1145 1731 1608 2044 9799 4685
Control 0 0 0 135 2348 3849 6088
LSC99I Vaccine 0 0 0 135 2602 6835 4396
Control 0 1145 1731 1608 1433 3748 3796
LTJ95I Vaccine 0 1145 1731 1608 1823 3883 3198
Control 0 0 0 135 1847 4614 3519

Values are antibody mean ± S.E.M.

a

Chickens (n = 12 per group) were immunized with recombinant fowlpox virus co-expressing the infectious bronchitis virus (IBV) S1 gene and the chicken interferon-γ gene at week 0.

b

Chickens (n = 12 per group) were challenged with 0.2 mL of allantoic fluid containing 10,000 EID50 of IBV strains LX4, LHLJ04XI, LHB, LSC99I and LTJ95I at week 3 post-vaccination.

c

Chicken sera were collected at weeks 0, 1, 2, 3, 4, 5 and 6.

d

Control chickens received PBS (n = 12 per group).